Literature DB >> 23270881

Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?

Judith A Groeneweg1, Paul A van der Zwaag, Jan D H Jongbloed, Moniek G P J Cox, Arnold Vreeker, Rudolf A de Boer, Jeroen F van der Heijden, Toon A B van Veen, William J McKenna, J Peter van Tintelen, Dennis Dooijes, Richard N W Hauer.   

Abstract

BACKGROUND: Arrhythmogenic cardiomyopathy (AC) is considered a predominantly right ventricular (RV) desmosomal disease. However, left-dominant forms due to desmosomal gene mutations, including PKP2 variant c.419C>T, have been described. Recently, a nondesmosomal phospholamban (PLN) mutation (c.40_42delAGA) has been identified, causing dilated cardiomyopathy and arrhythmias.
OBJECTIVE: To gain more insight into pathogenicity of the PKP2 variant c.419C>T by cosegregation analysis of the PKP2 variant c.419C>T vs the PLN mutation c.40_42delAGA.
METHODS: A Dutch family (13 family members, median age 49 years, range 34-71 years) with ventricular tachycardia underwent (1) meticulous phenotypic characterization and (2) screening of 5 desmosomal genes (PKP2, DSC2, DSG2, DSP, JUP) and PLN.
RESULTS: Six family members fulfilled 2010 AC Task Force Criteria. Seven had signs of left ventricular (LV) involvement (inverted T waves in leads V4-V6, LV wall motion abnormalities and late enhancement, and reduced LV ejection fraction), including 6 family members with proven AC. The PKP2 variant c.419C>T was found as a single variant in 3 family members, combined with the PLN mutation c.40_42delAGA in 3 others. PLN mutation was found in 9 family members, including the 6 with AC and all 7 with LV involvement. The PLN mutation c.40_42delAGA was found as a single mutation in 6, combined with the PKP2 variant c.419C>T in 3 others. A low-voltage electrocardiogram was seen in 4 of 9 PLN mutation-positive subjects. None of the family members with the single PKP2 variant showed any sign of RV or LV involvement.
CONCLUSIONS: The PLN mutation c.40_42delAGA cosegregates with AC and with electrocardiographic and structural LV abnormalities. In this family, there was no evidence of disease-causing contribution of the PKP2 variant c.419C>T.
Copyright © 2013 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23270881     DOI: 10.1016/j.hrthm.2012.12.020

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

Review 1.  Determined to Fail--the Role of Genetic Mechanisms in Heart Failure.

Authors:  Elham Kayvanpour; Hugo A Katus; Benjamin Meder
Journal:  Curr Heart Fail Rep       Date:  2015-10

2.  Plakophilin-2 c.419C>T and risk of heart failure and arrhythmias in the general population.

Authors:  Alex Hørby Christensen; Pia Rørbœk Kamstrup; Estelle Gandjbakhch; Marianne Benn; Jan Skov Jensen; Henning Bundgaard; Eric Villard; Anne Tybjærg-Hansen
Journal:  Eur J Hum Genet       Date:  2015-08-12       Impact factor: 4.246

3.  Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.

Authors:  Nour Raad; Philip Bittihn; Marine Cacheux; Dongtak Jeong; Zeki Ilkan; Delaine Ceholski; Erik Kohlbrenner; Lu Zhang; Chen-Leng Cai; Evangelia G Kranias; Roger J Hajjar; Francesca Stillitano; Fadi G Akar
Journal:  Circulation       Date:  2021-05-24       Impact factor: 39.918

Review 4.  Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update.

Authors:  Anneline S J M te Riele; Harikrishna Tandri; David A Bluemke
Journal:  J Cardiovasc Magn Reson       Date:  2014-07-20       Impact factor: 5.364

5.  Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age.

Authors:  M J van der Pols; T P Mast; P Loh; J F van der Heijden; M J Cramer; R N Hauer; A S J M Te Riele
Journal:  Neth Heart J       Date:  2016-12       Impact factor: 2.380

Review 6.  Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways.

Authors:  C J M van Opbergen; M Delmar; T A B van Veen
Journal:  Neth Heart J       Date:  2017-03       Impact factor: 2.380

Review 7.  Importance of Genetic Testing in Dilated Cardiomyopathy: Applications and Challenges in Clinical Practice.

Authors:  Arsonval Lamounier Júnior; Filipe Ferrari; Renato Max; Luiz Eduardo Fonteles Ritt; Ricardo Stein
Journal:  Arq Bras Cardiol       Date:  2019-09-02       Impact factor: 2.000

8.  A case report of arrhythmogenic ventricular cardiomyopathy presenting with sustained ventricular tachycardia arising from the right and the left ventricles before structural changes are documented.

Authors:  Bernard Belhassen; Haim Shmilovich; Eyal Nof; Anat Milman
Journal:  Eur Heart J Case Rep       Date:  2020-01-25

9.  Arrhythmogenic cardiomyopathy: diagnosis, genetic background, and risk management.

Authors:  J A Groeneweg; J F van der Heijden; D Dooijes; T A B van Veen; J P van Tintelen; R N Hauer
Journal:  Neth Heart J       Date:  2014-08       Impact factor: 2.380

10.  Phenotypic recapitulation and correction of desmoglein-2-deficient cardiomyopathy using human-induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Mikio Shiba; Shuichiro Higo; Takumi Kondo; Junjun Li; Li Liu; Yoshihiko Ikeda; Yasuaki Kohama; Satoshi Kameda; Tomoka Tabata; Hiroyuki Inoue; Satoki Nakamura; Maki Takeda; Emiko Ito; Seiji Takashima; Shigeru Miyagawa; Yoshiki Sawa; Shungo Hikoso; Yasushi Sakata
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.